Science Explorer Interactive view Map
Company · Shenzhen · ??

Shenzhen Chipscreen Biosciences Co.

Research works
21
▲ 7% vs 2013–17
Citations
581
27.9 per fractional work
Top-10% rate
15.8%
record average 16.5%
Open access
47%
world 28%

Not ranked overall: Shenzhen Chipscreen Biosciences Co. is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Shenzhen Chipscreen Biosciences Co.?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Transcriptional Regulation, Cancer Therapy, Metabolism, Cancer, Insulin Resistance, Diabetes and Obesity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 25 words, with their numbers
  1. Inflammation4▲ 8.9×10 topics
  2. Transcriptional Regulation3▲ 62×4 topics
  3. Cancer Therapy3▲ 24×7 topics
  4. Metabolism3▲ 21×8 topics
  5. Cancer3▲ 9.2×9 topics
  6. Insulin Resistance3▲ 28×5 topics
  7. Diabetes2▲ 24×3 topics
  8. Obesity2▲ 15×5 topics
  9. Epigenetic Regulation2▲ 51×4 topics
  10. Gene Expression2▲ 16×3 topics
  11. HDAC Inhibitors2▲ 498×1 topic
  12. Histone Deacetylases2▲ 498×1 topic
  13. Nuclear Receptors2▲ 51×2 topics
  14. PPARs2▲ 271×1 topic
  15. Peroxisome Proliferator-Activated Receptors2▲ 271×1 topic
  16. Tumor Microenvironment2▲ 21×5 topics
  17. Brown Adipose Tissue1▲ 86×1 topic
  18. Thermogenesis1▲ 86×1 topic
  19. BET Bromodomains1▲ 274×1 topic
  20. PROTACs1▲ 274×1 topic
  21. VEGF1▲ 162×1 topic
  22. endothelial progenitor cells1▲ 162×1 topic
  23. Herbal Medicine1▲ 23×2 topics
  24. Type 2 Diabetes1▲ 28×3 topics
  25. Bioactive Compounds1▲ 25×2 topics

Which research topics does Shenzhen Chipscreen Biosciences Co. publish most on?

By volume in 2022–2025: Thyroid Disorders and Treatments, Growth Hormone and Insulin-like Growth Factors, Liver Disease Diagnosis and Treatment and Peroxisome Proliferator-Activated Receptors.

  1. 1 Thyroid Disorders and Treatments Endocrinology, Diabetes and Metabolism 0 works
  2. 2 Growth Hormone and Insulin-like Growth Factors Endocrinology, Diabetes and Metabolism 0 works
  3. 3 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  4. 4 Peroxisome Proliferator-Activated Receptors Molecular Biology 0 works
  5. 5 Histone Deacetylase Inhibitors Research Molecular Biology 0 works
  6. 6 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
  7. 7 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
  8. 8 Protein Degradation and Inhibitors Molecular Biology 0 works
  9. 9 Hematopoietic Stem Cell Transplantation Hematology 0 works
  10. 10 Dermatology and Skin Diseases Dermatology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.6%not open53.4%

World: 28% of research is openly available.

with international co-authors8.0%domestic only92.0%

World: 19% is written across borders.

How has Shenzhen Chipscreen Biosciences Co.'s research output changed?

Output in 2018–2022 was 7% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Shenzhen

All research institutions in Shenzhen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.